To monitor levels of RAD51AP1 in cells we generated polyclonal antibodies using purified recombinant human RAD51AP1 as an antigen. The antibodies proved to be highly specific and were used to monitor the levels of RAD51AP1 in human HeLa cell extracts after siRNA-mediated down regulation. Four independent siRNAs targeted against RAD51AP1 were tested (Supplemental Figure 1A) . All four RAD51AP1-directed siRNAs induced substantial reduction of RAD51AP1 intracellular levels as early as 24 hrs post-transfection. Effective down regulation was maintained for at least 72 hrs post-transfection. All subsequent RAD51AP1 down regulation experiments were performed with siRNA #1 and #2, since they resulted in a highly efficient and reproducible down regulation of RAD51AP1.
Supplemental Results

Efficient down regulation of RAD51AP1 by siRNA
To monitor levels of RAD51AP1 in cells we generated polyclonal antibodies using purified recombinant human RAD51AP1 as an antigen. The antibodies proved to be highly specific and were used to monitor the levels of RAD51AP1 in human HeLa cell extracts after siRNA-mediated down regulation. Four independent siRNAs targeted against RAD51AP1 were tested (Supplemental Figure 1A) . All four RAD51AP1-directed siRNAs induced substantial reduction of RAD51AP1 intracellular levels as early as 24 hrs post-transfection. Effective down regulation was maintained for at least 72 hrs post-transfection. All subsequent RAD51AP1 down regulation experiments were performed with siRNA #1 and #2, since they resulted in a highly efficient and reproducible down regulation of RAD51AP1.
RAD51AP1 down regulation does not affect FANCD2 monoubiquitination or RAD51 expression levels
It is possible that the putative requirement for RAD51AP1 in RAD51-mediated DNA repair is indirect. RAD51AP1 could be part of the early cellular response to interstrand DNA crosslinking agents, of which FANCD2 mono-ubiquitination is a landmark event (Gurtan and D'Andrea, 2006; Henson et al., 2006) . Alternatively RAD51AP1 could indirectly affect the protein levels of RAD51.
However, neither the steady state levels of RAD51 nor FANCD2 monoubiquitination were affected after RAD51AP1 down regulation (Supplemental Figure 1B and C) . Effect of RAD51AP1 in RAD51-catalyzed D loop assays using homologous invading oligonucleotide SK3 and supercoiled pUC19 plasmid as recipient substrate. RAD51AP1 was added either before (lanes 4 and 9) or after (lanes 5 and 10) RAD51 during the filament assembly phase prior to addition of the recipient plasmid. Electrophoretic mobility shift assays using 2.5 nM of each DNA substrate.
RAD51AP1 started at a concentration of 500 nM and was titrated down in two-fold increments. DNA substrates were constructed with the indicated oligonucleotides for which the sequences can be found in Supplemental Table   2 . Position of the radiolabel on the substrates is indicated with an asterisk. Primary data is shown in Figure 7 . 
Supplemental Experimental Procedures Antibodies
Rabbit polyclonal antibodies R1085 and R1086 were raised against recombinant human RAD51AP1 and purified using protein A or protein G, respectively (Eurogentec). Guinea pigs polyclonal antibodies GP9 and GP10
were raised against recombinant human RAD51AP1 (Eurogentec). Rabbit polyclonal anti-hRAD51 antibodies (#2307) were described previously (Essers et al., 2002) . Mouse anti-RAD51 (#05-530) was obtained from Upstate.
Mouse anti-DMC1 (ab11054), rabbit anti-DMC1 (ab18254) and rabbit anti-XRCC3 (ab6494) antibodies were obtained from Abcam. Anti-GRB2
(#610111) was obtained from BD Transduction Laboratories. Anti-KU86 (SC-1484) was obtained from Santa Cruz Biotechnology. Anti-FANCD2 (NB100-316) was obtained from Novus Biologicals.
Immunoblotting
Cells were directly lysed with SDS sample buffer (2% SDS, 10% glycerol, 60 mM Tris-HCl (pH 6.8)). After the protein concentration was determined by the Lowry protein assay, extracts were supplemented with 0.5% β-mercaptoethanol and 0.02% bromophenol blue. Equal loading of proteins was independently verified by probing with anti-GRB2 or anti-KU86 antibodies.
After fractionation by SDS-PAGE, proteins were transferred to a nitrocellulose 
Plasmids
The human RAD51AP1 open reading frame (isoform1) 
Mass spectrometry
Purified RAD51AP1 was either buffer exchanged in a 50 mM ammonium acetate solution or dissolved in methanol at a concentration of 20 µM.
Samples were introduced into a quadrupole -time-of-flight mass spectrometer 
Electrophoretic mobility shift assays
Oligonucleotides used in this study are listed in Supplemental Table 2 .
Radiolabeled DNA substrates were prepared by 5' end labeling with T4 polynucleotide kinase and annealed as described (Ciccia et al., 2003) .
Binding reactions (10 µl) containing 20 mM Tris-HCl (pH 7.5), 120 mM KCl (unless indicated otherwise), 5% glycerol, 1 mM DTT, 2 mM EDTA, 0.1 mg/ml acetylated BSA, 0.01% Triton X100 and the indicated concentration of RAD51AP1 and DNA substrate were incubated for 30 min at room temperature. Before addition to the reaction tubes, RAD51AP1 was diluted in 20 mM Tris-HCl (pH 7.5), 300 mM KCl, 10% glycerol, 1 mM DTT, 1 mM EDTA, 0.1 mg/ml acetylated BSA. Reaction mixtures were fractionated by electrophoresis through 6% acrylamide gel in Tris-Borate buffer at 15 V/cm for 60 min unless otherwise indicated. Gels were dried on DEAE paper. Signals were captured by phosphorimaging using a Typhoon scanner and quantified using ImageQuant version 5.2 (Molecular dynamics).
D loop assays
RAD51 (1µM) (or DMC1) was incubated with the relevant 32 P-labeled ss DNA (3 µM nt, see Supplemental Table 2 ) in buffer containing 50 mM Tris-HCl (pH 7.5), 1 mM ATP, 100 µg/ml BSA, 1 mM DTT, 2 mM MgCl 2 and 30 mM KCl Gels were dried on DEAE paper. Signals were captured by phosphorimaging using a Typhoon scanner and quantified using ImageQuant version 5.2 (Molecular dynamics). Given the low levels of the intrinsic RAD51 D loop formation efficiency under Mg 2+ / ATP conditions, accurate measurements of the absolute yield of product of this baseline reaction are difficult to obtain as described previously (Bugreev and Mazin, 2004) .
